You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -71.1% | -16.4% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.8 | 0.6 |
| Price / Book value | -19.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 145.9% | -42.9% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 35,186.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 10.39 | -1.89 | -1.89p | -31.8 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 1.52 | -19.91 | -10.00p | -4.3 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 5.50 | -49.43 | -21.00p | -0.3 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 13.09 | -32.38 | -5.00p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2024-12-31 | 32.18 | -26.56 | -3.00p | -0.9 | 0.0 | n/a | n/a | 0.0% |
| Shield Therapeutics inks exclusive licence agreement in Japan Sharecast News | 22 Apr |
|---|---|
| Shield Therapeutics appoints Anders Lundstrom as permanent CEO Sharecast News | 27 Jan |
| Shield Therapeutics secures $10m investment, announces RetailBook offer Sharecast News | 06 Dec |
| Result of AGM | 22-May-25 17:06 |
|---|---|
| Audited results for the year ended 31 Dec 2024 | 24-Apr-25 07:06 |
| Licence Agreement in Japan for ACCRUFeR® | 22-Apr-25 07:02 |
| Q1 2025 Trading Update | 17-Apr-25 11:23 |
| ACCRUFeR® launched in Canada | 11-Mar-25 07:01 |